Using psychedelics to treat chronic pain is understudied yet full of potential.
“In the pharmaceutical drug development community, this is what you dream about.”
Three doses of fluoxetine were needed to elicit the effects of one dose of noribogaine.
This collaboration will determine the full scope of the pharmacological effects of several synthetic tryptamine compounds.
This is the first preclinical study to examine the anti-depressive effects of ibogaine and noribogaine.
Understanding the structure of this synthetic analog of 5-MeO-DMT may help explain the effects of naturally occurring chemical cocktails.
New crystalline forms of norpsilocin create new options for developing psychedelic drug formulations.
Understanding brain morphology differences may prove essential for creating effective psychedelic drug formulations.
Morris has insightful ideas for studying psychedelic toad secretions while prioritizing the conservation of toads.
Environment and diet may play a role in the alkaloid content of secretions from a Brazilian toad species.